News tagged with side effects
Related topics: drug , patients , food and drug administration , cancer , clinical trials
The hunt for a successor to lithium for bipolar disorder
Toxicity problems and adverse side effects when taking lithium, the mainstay medication for treating bipolar disorder, are fostering a scientific hunt for insights into exactly how lithium works in the body—with an eye ...
Psychology & Psychiatry
Mar 27, 2013 |
not rated yet |
0
Researchers studying ketamine as suicide prevention drug
(Medical Xpress)—University of Alabama at Birmingham (UAB) researchers think ketamine, an anesthesia medication in use since the 1970s, might be a valuable tool in treating severe depression and reducing ...
Psychology & Psychiatry
Mar 27, 2013 |
5 / 5 (1) |
0
Antipsychotic meds not that helpful for depression, study finds
(HealthDay)—For people who don't fully respond to antidepressants, adding commonly prescribed antipsychotic drugs appears to be only slightly effective and is linked to unwelcome side effects, a new study ...
Psychology & Psychiatry
Mar 12, 2013 |
not rated yet |
0
|
ACC: Niacin/Laropiprant no benefit in vascular disease
(HealthDay)—For patients with preexisting occlusive vascular disease, the combination of niacin and the anti-flushing agent laropiprant provides no benefit and is associated with an increase in serious ...
Cardiology
Mar 12, 2013 |
not rated yet |
0
Researchers find alternative cholesterol-lowering drug for patients who can't tolerate statins
Heart patients who can't tolerate the side effects of cholesterol-lowering drugs may have a new option, according to a new study by researchers from the Intermountain Heart Institute at Intermountain Medical Center in Salt ...
Cardiology
Mar 11, 2013 |
5 / 5 (2) |
0
Scientists eradicate lung tumors in a pre-clinical mouse model
The study, led by the Vall d'Hebron Institute of Oncology (VHIO), has managed to eliminate mouse lung tumours by inhibiting Myc, a protein that plays a key role in the development of many different tumours. The results, to ...
Cancer
Mar 07, 2013 |
5 / 5 (1) |
0
Oestrogen patches could offer a new treatment option for prostate cancer patients
Patches giving oestrogen through the skin could be an easy and safe alternative to the hormone therapies used to treat prostate cancer, according to new research published in the Lancet Oncology, today (Monday).
Cancer
Mar 04, 2013 |
not rated yet |
0
Study identifies growth factor essential to the most common malignant pediatric brain tumor
A multi-institutional team led by Massachusetts General Hospital (MGH) researchers has identified a molecular pathway that appears to be essential for the growth and spread of medulloblastoma, the most common ...
Cancer
Feb 28, 2013 |
not rated yet |
0
|
Most parents believe vaccines are safe for children, research finds
(Medical Xpress)—New research from the University of Adelaide shows that 95% of parents believe vaccines are safe for their children despite the spread of misinformation about vaccine safety.
Medications
Feb 27, 2013 |
not rated yet |
0
Virus shows promise as prostate cancer treatment
A recombinant Newcastle disease virus kills all kinds of prostate cancer cells, including hormone resistant cells, but leaves normal cells unscathed, according to a paper published online ahead of print in the Journal of ...
Cancer
Feb 25, 2013 |
5 / 5 (3) |
0
|
Sniffing out the side effects of radiotherapy may soon be possible
Researchers at the University of Warwick and The Royal Marsden NHS Foundation Trust have completed a study that may lead to clinicians being able to more accurately predict which patients will suffer from the side effects ...
Medical research
Feb 21, 2013 |
not rated yet |
0
|
Cure in sight for kissing bug's bite
Chagas disease, a deadly tropical infection caused by the protozoan parasite Trypanosoma cruzi and transmitted by biting insects called "kissing bugs," has begun to spread around the world, including the U.S. Yet current treatm ...
Medications
Feb 14, 2013 |
not rated yet |
0
Could duration of prostate cancer hormone therapy be halved?
(HealthDay)—For some men with prostate cancer, hormonal therapy to beat the disease could be safely cut from three years to half that time, a new clinical trial suggests.
Cancer
Feb 13, 2013 |
5 / 5 (1) |
0
|
Bevacizumab significantly improves survival for patients with recurrent and metastatic cervical cancer
(Medical Xpress)—Patients with advanced, recurrent, or persistent cervical cancer that was not curable with standard treatment who received the drug bevacizumab (Avastin) lived 3.7 months longer than patients who did not ...
Cancer
Feb 08, 2013 |
not rated yet |
0
Doctors' perceptions of psoriasis therapies vary
(HealthDay)—Doctors who treat patients with psoriasis show wide variation in their beliefs about the safety and effectiveness of psoriasis treatments, according to a study published in the February issue ...
Diseases, Conditions, Syndromes
Feb 07, 2013 |
not rated yet |
0
